Immunotherapy involving the administration of interferon-α for the treatment of hepatitis C or cancer has been shown to induce the production of proinflammatory cytokines such as interleukin-6 and depression among a considerable number of patients (Bonaccorso et al. 2002; Juengling et al. 2000). This evidence concerns the gene IL6 and depressive symptom measurement.